Clinical Trial Update: 18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating 18F-PSMA-1007 PET imaging for detecting primary prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-PSMA-1007 (PSMA-1007 radiotracer)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED